Chitosan derivatives as nanocarriers for hLDHA inhibitors delivery to hepatic cells: A selective strategy for targeting primary hyperoxaluria diseases

  1. Salido, S.
  2. Alejo-Armijo, A.
  3. Parola, A.J.
  4. Sebastián, V.
  5. Alejo, T.
  6. Irusta, S.
  7. Arruebo, M.
  8. Altarejos, J.
Aldizkaria:
International Journal of Pharmaceutics

ISSN: 1873-3476,  0378-5173

Argitalpen urtea: 2022

Alea: 627

Mota: Artikulua

DOI: 10.1016/J.IJPHARM.2022.122224 GOOGLE SCHOLAR lock_openSarbide irekia editor